Infectious Diseases
June 14, 2022
ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir,[...]
January 6, 2012
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community